Cargando…

SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China

Objectives: To explore and understand the SARS-CoV-2 seroprevalence of convalescents, the association between antibody levels and demographic factors, and the seroepidemiology of convalescents of COVID-19 till March 2021. Methods: We recruited 517 voluntary COVID-19 convalescents in Sichuan Province...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Lijun, Li, Cheng, Yang, Huiping, Yuan, Heng, Pan, Ming, Cheng, Xiuwei, Xiao, Chongkun, Su, Xiaoyan, Zhu, Yuanfang, Xu, Jianan, Tang, Jianxiang, Du, Xunbo, Peng, Huanwen, Chen, Xiao, Huang, Tao, Liao, Hongxiu, Xian, Deqiang, Wang, HaoZhou, Liu, Wenwu, Zhou, Ping, Zhang, Zhengdong, Liu, Juan, Wu, Xianping, Zhang, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577692/
https://www.ncbi.nlm.nih.gov/pubmed/34765580
http://dx.doi.org/10.3389/fpubh.2021.716483
_version_ 1784596111889006592
author Zhou, Lijun
Li, Cheng
Yang, Huiping
Yuan, Heng
Pan, Ming
Cheng, Xiuwei
Xiao, Chongkun
Su, Xiaoyan
Zhu, Yuanfang
Xu, Jianan
Tang, Jianxiang
Du, Xunbo
Peng, Huanwen
Chen, Xiao
Huang, Tao
Liao, Hongxiu
Xian, Deqiang
Wang, HaoZhou
Liu, Wenwu
Zhou, Ping
Zhang, Zhengdong
Liu, Juan
Wu, Xianping
Zhang, Tao
author_facet Zhou, Lijun
Li, Cheng
Yang, Huiping
Yuan, Heng
Pan, Ming
Cheng, Xiuwei
Xiao, Chongkun
Su, Xiaoyan
Zhu, Yuanfang
Xu, Jianan
Tang, Jianxiang
Du, Xunbo
Peng, Huanwen
Chen, Xiao
Huang, Tao
Liao, Hongxiu
Xian, Deqiang
Wang, HaoZhou
Liu, Wenwu
Zhou, Ping
Zhang, Zhengdong
Liu, Juan
Wu, Xianping
Zhang, Tao
author_sort Zhou, Lijun
collection PubMed
description Objectives: To explore and understand the SARS-CoV-2 seroprevalence of convalescents, the association between antibody levels and demographic factors, and the seroepidemiology of convalescents of COVID-19 till March 2021. Methods: We recruited 517 voluntary COVID-19 convalescents in Sichuan Province and collected 1,707 serum samples till March 2021. Then we reported the seroprevalence and analyzed the associated factors. Results: Recent travel history was associated with IgM levels. Convalescents who had recent travel history were less likely to be IgM antibody negative [OR = 0.232, 95% CI: (0.128, 0.420)]. Asymptomatic cases had, approximately, twice the odds of being IgM antibody negative compared with symptomatic cases [OR = 2.583, 95% CI: (1.554, 4.293)]. Participants without symptoms were less likely to be IgG seronegative than those with symptoms [OR = 0.511, 95% CI: (0.293, 0.891)]. Convalescents aged 40–59 were less likely to be IgG seronegative than those aged below 20 [OR = 0.364, 95% CI: (0.138, 0.959)]. The duration of positive IgM antibodies persisted 365 days while the IgG persisted more than 399 days. Conclusions: Our findings suggested that recent travel history might be associated with the antibody levels of IgM, while age could be associated with the antibody levels of IgG. Infection type could be associated with both antibody levels of IgM and IgG that declined quicker in asymptomatic cases.
format Online
Article
Text
id pubmed-8577692
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85776922021-11-10 SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China Zhou, Lijun Li, Cheng Yang, Huiping Yuan, Heng Pan, Ming Cheng, Xiuwei Xiao, Chongkun Su, Xiaoyan Zhu, Yuanfang Xu, Jianan Tang, Jianxiang Du, Xunbo Peng, Huanwen Chen, Xiao Huang, Tao Liao, Hongxiu Xian, Deqiang Wang, HaoZhou Liu, Wenwu Zhou, Ping Zhang, Zhengdong Liu, Juan Wu, Xianping Zhang, Tao Front Public Health Public Health Objectives: To explore and understand the SARS-CoV-2 seroprevalence of convalescents, the association between antibody levels and demographic factors, and the seroepidemiology of convalescents of COVID-19 till March 2021. Methods: We recruited 517 voluntary COVID-19 convalescents in Sichuan Province and collected 1,707 serum samples till March 2021. Then we reported the seroprevalence and analyzed the associated factors. Results: Recent travel history was associated with IgM levels. Convalescents who had recent travel history were less likely to be IgM antibody negative [OR = 0.232, 95% CI: (0.128, 0.420)]. Asymptomatic cases had, approximately, twice the odds of being IgM antibody negative compared with symptomatic cases [OR = 2.583, 95% CI: (1.554, 4.293)]. Participants without symptoms were less likely to be IgG seronegative than those with symptoms [OR = 0.511, 95% CI: (0.293, 0.891)]. Convalescents aged 40–59 were less likely to be IgG seronegative than those aged below 20 [OR = 0.364, 95% CI: (0.138, 0.959)]. The duration of positive IgM antibodies persisted 365 days while the IgG persisted more than 399 days. Conclusions: Our findings suggested that recent travel history might be associated with the antibody levels of IgM, while age could be associated with the antibody levels of IgG. Infection type could be associated with both antibody levels of IgM and IgG that declined quicker in asymptomatic cases. Frontiers Media S.A. 2021-10-26 /pmc/articles/PMC8577692/ /pubmed/34765580 http://dx.doi.org/10.3389/fpubh.2021.716483 Text en Copyright © 2021 Zhou, Li, Yang, Yuan, Pan, Cheng, Xiao, Su, Zhu, Xu, Tang, Du, Peng, Chen, Huang, Liao, Xian, Wang, Liu, Zhou, Zhang, Liu, Wu and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Zhou, Lijun
Li, Cheng
Yang, Huiping
Yuan, Heng
Pan, Ming
Cheng, Xiuwei
Xiao, Chongkun
Su, Xiaoyan
Zhu, Yuanfang
Xu, Jianan
Tang, Jianxiang
Du, Xunbo
Peng, Huanwen
Chen, Xiao
Huang, Tao
Liao, Hongxiu
Xian, Deqiang
Wang, HaoZhou
Liu, Wenwu
Zhou, Ping
Zhang, Zhengdong
Liu, Juan
Wu, Xianping
Zhang, Tao
SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China
title SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China
title_full SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China
title_fullStr SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China
title_full_unstemmed SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China
title_short SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China
title_sort sars-cov-2 seroprevalence and profiles among convalescents in sichuan province, china
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577692/
https://www.ncbi.nlm.nih.gov/pubmed/34765580
http://dx.doi.org/10.3389/fpubh.2021.716483
work_keys_str_mv AT zhoulijun sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT licheng sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT yanghuiping sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT yuanheng sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT panming sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT chengxiuwei sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT xiaochongkun sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT suxiaoyan sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT zhuyuanfang sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT xujianan sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT tangjianxiang sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT duxunbo sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT penghuanwen sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT chenxiao sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT huangtao sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT liaohongxiu sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT xiandeqiang sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT wanghaozhou sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT liuwenwu sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT zhouping sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT zhangzhengdong sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT liujuan sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT wuxianping sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina
AT zhangtao sarscov2seroprevalenceandprofilesamongconvalescentsinsichuanprovincechina